Novabay Pharmaceuticals Inc [AMEX: NBY] surged by $0.0 during the normal trading session on while it closed the day at $0.08. Novabay Pharmaceuticals Inc stock has also loss -9.40% of its value over the past 7 days. However, NBY stock has declined by -48.76% in
Novabay Pharmaceuticals Inc [AMEX: NBY] traded at a high on Tuesday, posting a 7.83 gain after which it closed the day’ session at $0.14. The results of the trading session contributed to over 11344833 shares changing hands. Over the past one week, the price volatility
Novabay Pharmaceuticals Inc [AMEX: NBY] price plunged by -4.87 percent to reach at -$0.01. The company report on March 14, 2024 at 8:00 AM that NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year
Novabay Pharmaceuticals Inc [AMEX: NBY] jumped around 0.01 points on Thursday, while shares priced at $0.16 at the close of the session, up 5.09%. The company report on January 30, 2024 at 9:00 AM that NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based
Novabay Pharmaceuticals Inc [AMEX: NBY] slipped around -0.02 points on Tuesday, while shares priced at $0.13 at the close of the session, down -11.13%. The company report on January 30, 2024 at 9:00 AM that NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based
Novabay Pharmaceuticals Inc [AMEX: NBY] surged by $0.02 during the normal trading session on while it closed the day at $0.18. The company report on January 9, 2024 at 9:15 AM that NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European
© 2024, Powered by Smart TechOne
